Literature DB >> 29986595

Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers.

Sumei Wang1,2,3, Shunqin Long1,3, Wanyin Wu1,3.   

Abstract

Although lots of great achievements have been gained in the battle against cancer during the past decades, cancer is still the leading cause of death in the world including in developing countries such as China. Traditional Chinese medicine (TCM) is popular in Chinese and East Asian societies as well as some other Western countries and plays an active role in the modern healthcare system including patients with cancer, which may act as a potential effective strategy in treating human cancers. In this review, we aimed to introduce the mechanisms of TCM compound, as an option of individualized therapy, in treating cancer patients from the perspective of both Chinese and Western medicine. In the view of traditional Chinese medicine theory, individualized treatment for human cancers based on syndrome type benefits the cancer patients with personalized conditions. Balancing Qi, Xue, Yin and Yang, eliminating phlegm and removing dampness is how TCM compound functions on cancer patients. While in the view of Western medicine, inhibiting cancer cell growth and metastasis as well as improving immune status is how herbal compounds act on cancer patients. We also summarized the applications of TCM compound in human cancers, which will shed light on the clinical application of TCM compound on patients with cancer. TCM compound could be used as a complementary and alternative medicine (CAM) in human cancers. It could be applied in cancer patients with cancer-related fatigue (CRF). In addition, it is a good method for alleviating the side effects of both radiotherapy and chemotherapy. Therefore, TCM compound plays a critical role in treating patients with cancer, which has a promising strategy in the field of cancer management.

Entities:  

Keywords:  Cancer-Related Fatigue (CRF); Chinese Herbal Medicine (CHM); Complementary and Alternative Medicine (CAM); Human Cancer; Personalized Therapy; Review; Traditional Chinese Medicine (TCM) Compound

Mesh:

Substances:

Year:  2018        PMID: 29986595     DOI: 10.1142/S0192415X18500507

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  22 in total

1.  Effect of the Early Start Denver Model on Children With Autism Spectrum Disorder Syndrome of Different Traditional Chinese Medicine Types in Northeast China.

Authors:  Lili Wang; Junyan Feng; Yu Zhang; Tiantian Wang
Journal:  Front Pediatr       Date:  2022-03-29       Impact factor: 3.418

Review 2.  Meta-Analysis of Xihuang Pill Efficacy When Combined with Chemotherapy for Treatment of Breast Cancer.

Authors:  Dan Mao; Lei Feng; Siqi Huang; Shaofan Zhang; Weijun Peng; Sifang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2019-03-12       Impact factor: 2.629

Review 3.  Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges.

Authors:  Yi Liu; Wenping Wang; Mingyi Sun; Baorui Ma; Linnuo Pang; Yuanyuan Du; Xiaoxv Dong; Xingbin Yin; Jian Ni
Journal:  Front Pharmacol       Date:  2019-12-13       Impact factor: 5.810

4.  Ethanol Extracts of Solanum lyratum Thunb Regulate Ovarian Cancer Cell Proliferation, Apoptosis, and Epithelial-to-Mesenchymal Transition (EMT) via the ROS-Mediated p53 Pathway.

Authors:  Chen Zhang; Zheming Li; Jie Wang; Xuelu Jiang; Mengting Xia; Jianfen Wang; Shenyi Lu; Shouye Li; Hanmei Wang
Journal:  J Immunol Res       Date:  2021-04-01       Impact factor: 4.818

5.  Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis.

Authors:  Chuihua Sun; Fang Dong; Ting Xiao; Wenni Gao
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

6.  Analysis of Colorectal Carcinogenesis Paradigm between Cold Constitution and Heat Constitution: Earlier ECM Collagen Deposition.

Authors:  Feifei Nong; Yuqi Liang; Shangping Xing; Huixuan Li; Xizheng Lin; Jingchun Qin; Fengliang Hu; Bin Wen
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-17       Impact factor: 2.629

7.  Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H22 Hepatocellular Carcinoma-Bearing Mice: By Targeting Myeloid-Derived Suppressor Cells.

Authors:  Yingjie Xie; Yuan Zhang; Xiaohan Wei; Cheng Zhou; Yajing Huang; Xingwang Zhu; Yongxu Chen; Huihong Wen; Xuhui Huang; Juze Lin; Ziying Wang; Yan Ren; Baochao Fan; Xue Deng; Wei Tan; Changjun Wang
Journal:  Front Pharmacol       Date:  2020-02-18       Impact factor: 5.810

8.  XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.

Authors:  Yifeng Zheng; Neng Wang; Shengqi Wang; Bowen Yang; Honglin Situ; Lidan Zhong; Yi Lin; Zhiyu Wang
Journal:  Cell Commun Signal       Date:  2020-03-26       Impact factor: 5.712

Review 9.  Trends and Future Direction of the Clinical Decision Support System in Traditional Korean Medicine.

Authors:  Hyun-Kyung Sung; Boyung Jung; Kyeong Han Kim; Soo-Hyun Sung; Angela-Dong-Min Sung; Jang-Kyung Park
Journal:  J Pharmacopuncture       Date:  2019-12-31

10.  Nonsurgical treatment of chronic subdural hematoma with Chinese herbal medicine: A STROBE-compliant retrospective study.

Authors:  Yanping Tong; Weiming Liu; Long Xu; Yunwei Ou; Kangning Li; Tao Yang; Tianyou Zhao; Ruixi Guan; Yongping Fan
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.